## Gene Summary
CCL11, also known as eotaxin, is a gene that encodes a member of the CC chemokine family of cytokines which have a critical role in immune responses. CCL11 selectively recruits eosinophils by inducing their chemotaxis, and is involved in processes such as allergic responses and the pathophysiology of asthma. The protein functions by binding to the chemokine receptor CCR3. It is primarily expressed in various structures within the body including the lung, small intestine, and thymus.

## Gene Drugs, Diseases, Phenotypes, and Pathways
CCL11 is predominantly linked to conditions characterized by an eosinophilic response, such as allergic diseases, asthma, and eosinophilic esophagitis. The overexpression of CCL11 has been associated with exacerbated allergic inflammatory conditions. Due to its role in recruiting eosinophils, CCL11 has been a target for therapeutic intervention in diseases with prominent eosinophilic inflammation. The gene is involved in signaling pathways that regulate immune system responses and inflammation, and it interacts with other chemokines and receptors in the immune network.

## Pharmacogenetics
In the context of pharmacogenetics, CCL11 is of interest particularly in its modulation during anti-inflammatory and anti-allergic drug therapies. Although direct associations with specific drugs in a pharmacogenetic context are not extensively documented, the gene's influence on the efficacy of corticosteroids and other anti-inflammatory agents can be inferred. Drugs targeting the CCR3 receptor or other elements of the eosinophil recruitment pathway could potentially be influenced by the genetic variants of CCL11, altering drug response or effectiveness in treating asthma and other allergic conditions. Further research into CCL11's pharmacogenetics might enhance personalized treatment strategies in allergy and asthma therapy.